Pregled bibliografske jedinice broj: 359319
The growth advantage in stationary-phase (GASP) phenomenon in mixed cultures of enterobacteria
The growth advantage in stationary-phase (GASP) phenomenon in mixed cultures of enterobacteria // FEMS Microbiology Letters, 266 (2007), 1; 119-127 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 359319 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
The growth advantage in stationary-phase (GASP) phenomenon in mixed cultures of enterobacteria
Autori
Bačun-Družina, Višnja ; Čagalj, Željka ; Gjuračić, Krešimir
Izvornik
FEMS Microbiology Letters (0378-1097) 266
(2007), 1;
119-127
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
growth advantage in stationary phase; GASP; Escherichia coli; Salmonella enterica; streptomycin resistance; nalidixic acid resistance
Sažetak
Growth advantage in stationary phase (GASP) is the term used to describe the ability of mutants with an increased fitness from 10-day-old enterobacteria culture to out-compete 1-day-old cells of the same initial strain during a prolonged stationary phase, although the aged cells are introduced as a minority. We studied this bacterial trait in mixed cultures of two enterobacterial species, Escherichia coli and Salmonella enterica, wild type in addition to derived mutants from both strains that contain chromosomal-encoded resistance to either nalidixic acid or streptomycin. The strong GASP phenotype was obtained in mixed cultures with the aged mutant strains, but not when the isogenic antibiotic-sensitive strains were used. This phenomenon was associated with chromosomal rearrangements in 10-day-old bacterial antibiotic-resistant mutated cells.
Izvorni jezik
Engleski
Znanstvena područja
Biologija, Biotehnologija
POVEZANOST RADA
Ustanove:
Prehrambeno-biotehnološki fakultet, Zagreb,
Fidelta d.o.o.
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE